CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells - Wikidata - thesis-toulmin - TriplyDB

CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells

CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells

http://www.wikidata.org/entity/Q57222163

about

Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis Interferon-alpha, immune activation and immune dysfunction in treated HIV infection Host-pathogen interaction in HIV infection CD8 T cell persistence in treated HIV infection Intact type I Interferon production and IRF7 function in sooty mangabeys HIV-1 and hijacking of the host immune system: the current scenario.Systemic effects of inflammation on health during chronic HIV infection Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis.Immunologic strategies for HIV-1 remission and eradication.Residual immune dysregulation syndrome in treated HIV infection.Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production Persistent immune activation in chronic HIV infection: do any interventions work?Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus.Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.Evaluation of different antiretroviral drug protocols on naturally infected feline immunodeficiency virus (FIV) cats in the late phase of the asymptomatic stage of infection.Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.Proteome and Protein Network Analyses of Memory T Cells Find Altered Translation and Cell Stress Signaling in Treated Human Immunodeficiency Virus Patients Exhibiting Poor CD4 Recovery.Plasmacytoid dendritic cells in HIV infection.Highly active anti-hepatitis C therapy: seven lessons from HIV.Interferons and HIV Infection: The Good, the Bad, and the Ugly Prevention of SHIV transmission by topical IFN-β treatment.HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx.Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.Will loss of your MAITs weaken your HAART [corrected]?Microbial translocation in HIV infection: causes, consequences and treatment opportunities.Peginterferon α-2a for the treatment of HIV infection.Discordance between peripheral and colonic markers of inflammation during suppressive ART Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.The interferon paradox: can inhibiting an antiviral mechanism advance an HIV cure?Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a Difference Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection.Exacerbated apoptosis of cells infected with infectious bursal disease virus (IBDV) upon exposure to Interferon alpha (IFN-α).

P2860

Q26747110-942C64A6-E133-4482-A22B-EAE36707ACBB Q26861003-92D28690-3A9B-40CA-8943-30B1A881466F Q27009024-F6B02B54-A5D6-484B-ABFC-4CB43D4D8C42 Q27014768-5C51782F-AD0C-49F3-B4DE-73EC4BCA96BF Q27333543-5FCF287A-C064-48EF-8308-54873070A3ED Q30248405-755208B0-1419-46B8-89D4-4B68A7EF1CDD Q33577551-89CA9DC2-2C80-4397-94F0-4121D3BEE26A Q33803416-59E50EB4-07BF-4099-B594-F676039E06A1 Q33896523-8B842F82-E50C-428B-8B35-30A8A4A86DA4 Q34020121-79DFD23C-03EC-416F-BA9D-E654A827C642 Q34292033-76986E97-DCBE-4DAD-B2EB-F35CEE284601 Q34851102-AB58F472-1852-49A3-BD0D-D21417322100 Q34943158-9EB6E265-71C8-4404-AB55-DD9990C4F68F Q34983614-BD88F674-7E94-4581-9AFD-E70CE5FD7DC7 Q35018048-E6BC6DDE-6A9F-45D7-A44C-56BBBCFDB5F7 Q35564886-7EBB1F60-F045-4DD3-B4ED-636C20D658BE Q35627713-765022BE-B7D1-48E3-A007-C8D428109D69 Q36096402-14DF9610-F005-435B-B74E-54A7EC6E863A Q36678143-EA317949-B9B0-42AD-9514-B9D10D3A654C Q36854142-E921675D-CE8D-4CFA-826C-474CABF4B1F3 Q36900071-A7566122-F678-40F3-98F7-2297E804AC6B Q37019332-DB6DE96E-AD76-4928-A4F1-1265E989B3BB Q37025212-F2106128-95F5-4A04-8732-2B9D9F678A5E Q37149862-22CA9B43-986B-432F-BC6F-458DC3CB762A Q37150111-B197BAE8-116A-4FA2-AF4C-542834963EB6 Q37543254-90B2C417-21AF-40CE-87BE-F465B5E6F594 Q37545050-F8C3E73B-A0D9-4577-803E-6868D772C420 Q37707466-CB97FC61-1680-4DA4-8B73-CA90DD22DAD1 Q37732225-266D85C1-9B4F-4767-B258-A9D0B3133287 Q38034068-76BD677A-54BB-43AB-B6AF-0089990616F3 Q38669306-1CBC0278-3D14-4785-8D3B-A10575A99696 Q38930864-9495AABE-BDDF-41EF-AB75-B24198C8E2EB Q40160105-7DC8EF9B-97A5-43B9-9B7A-5971DBF72E23 Q40395105-D3FF3935-2062-425C-B4BA-19375DD64862 Q40414181-06E68EEA-D359-47FF-8209-CDB8D32554EB Q40669752-26125CF0-C23E-4A67-B508-C6E08ED88810 Q42369099-586E499F-3052-4520-9450-2A26F8F471F7 Q47558114-3C118620-4107-4DE8-B694-BC2AE6B9C18B Q52653905-61FC42DB-F74C-4F5B-A85A-1375BA885EE4 Q52655443-ECECCF9F-0957-4ED6-99A2-D12F44DDE9CB

P2860

CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells

http://www.wikidata.org/entity/Q57222163

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

CD4+ T-Cell Deficiency in HIV ...... imulated Genes in CD4+ T Cells

@en

CD4+ T-Cell Deficiency in HIV ...... imulated Genes in CD4+ T Cells

@nl

type

label

CD4+ T-Cell Deficiency in HIV ...... imulated Genes in CD4+ T Cells

@en

CD4+ T-Cell Deficiency in HIV ...... imulated Genes in CD4+ T Cells

@nl

prefLabel

CD4+ T-Cell Deficiency in HIV ...... imulated Genes in CD4+ T Cells

@en

CD4+ T-Cell Deficiency in HIV ...... imulated Genes in CD4+ T Cells

@nl

P1433

Q57222163-FCA6FF5A-48AA-43C0-AB5C-6CB929CC3FB2

P1476

Q57222163-BE7CA5DD-D155-4EE2-880D-C943165B1123

P2093

Q57222163-29431390-CDB1-4841-84C1-124E7A9C52CC

Q57222163-97190E28-4CCF-42B4-8671-9DB77E434D88

Q57222163-AB811E40-0652-4C4E-A6AC-695E02000830

P2860

Q57222163-1CD97716-3089-47E5-B108-4CEC8EFE9740

Q57222163-2E5B84A9-F544-46F6-A608-F840E5E37971

Q57222163-309BBBBE-9735-4318-97BD-E8086CD57B03

Q57222163-39130CB1-8F66-451D-8E19-7B4F98F722F5

Q57222163-3B4D8D6F-3945-479E-88CD-AA6D83EF6E75

Q57222163-41DA1D6D-0175-48B5-8D57-CAC25E7420F9

Q57222163-43CAE690-1956-4A5B-B655-360DAD6F535A

Q57222163-454FBD41-A622-4466-B64C-3575D4135152

Q57222163-4746355F-1F93-4031-8D15-D63B353BCCB1

Q57222163-4F798A48-A76E-4357-A233-B567B0F40126

P304

Q57222163-00D487A3-1EA8-438F-B0F5-B98B05236B81

P31

Q57222163-2D8F6237-9E44-4623-AEAE-565BC316C4A5

P356

Q57222163-E3540C23-8074-4638-93BA-20DDF127FF77

P407

Q57222163-78D1F744-FEF8-4B84-84A1-389798F510BF

P433

Q57222163-531D923E-26BC-406B-B402-DCDC04BEDFDC

P478

Q57222163-FB637318-5EA4-48C3-B8D2-59A679BBCCE3

P50

Q57222163-32EEC214-072C-4202-A797-D6070606DBF3

Q57222163-6A1B33EC-94CA-4E7E-B21D-41916F50D67F

Q57222163-73DFF8C1-B940-42DB-AE26-DBE62A969ADD

Q57222163-AE2DF334-FA83-4B07-85C8-D130492A3306

Q57222163-B7C2FFA8-34AA-4A7A-9BBC-087F5E8FA792

Q57222163-BEC5F317-FF86-4371-A538-75385E52F618

Q57222163-E0B39917-3571-4E95-8758-2E68B539AB9C

Q57222163-EC40A11D-4176-4AC9-8FB6-61EBC2D2F729

P577

Q57222163-CCF9636D-0B30-49E8-98CB-3F9D22CF4FC6

P698

Q57222163-E3472648-3645-43D1-A9D2-1F41A4F0523C

P921

Q57222163-9D2E37BC-1ECC-4DE3-8481-14D1850DA201

P356

P1433

The Journal of Infectious Diseases

P1476

CD4+ T-cell deficiency in HIV ...... imulated genes in CD4+ T cells

@en

P2093

Marit Kramski

http://www.w3.org/2001/XMLSchema#string

Patricia Price

http://www.w3.org/2001/XMLSchema#string

Sara Tanaskovic

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.

Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.

Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.

Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

P304

1927-1935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIR659

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Sharon R. Lewin

Anthony W. Purcell

Sonia Fernandez

Martyn A. French

Reena Rajasuriar

Michael R Beard

P577

2011-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22006994

http://www.w3.org/2001/XMLSchema#string

P921